However, the relationships between BCL6 and its potential interacting partners have yet to be explored in CML, but this data provides a rationale for examining the links between BCL6 and histone deacetylases – both of which are survival factors in CML. Here, BCL6 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.